chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever up to 106; headaches; muscle pains; chills; nausea; This is a spontaneous report from a contactable consumer or other non hcp. A 53-years-old male patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 21Mar2021 15:45 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included meloxicam (MELOXICAM) taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient did not receive other vaccine in four weeks of vaccination. Patient received Meloxicam as medications in two weeks of vaccination. Patient had no allergies to medications, food, or other products. Ethnicity information was available. On 21Mar2021 15:45 the patient experienced fever up to 106, headaches, muscle pains, chills, nausea. The patient underwent lab tests and procedures which included body temperature: 106 Fahrenheit on 21Mar2021 fever up to 106. The outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 30-JAN-2015 the patient was inadvertently vaccinated with RECOMBIVAX HB, intramuscularly, dose: 1 ml, lot # H013865 which expired on 13-JAN-2015. No adverse effects were reported for the patient. Additional information is not expected because the reporter did not give a consent for the follow up.
PATIENT IS 17YEARS AND 3 MONTHS.  THE NURSE ADMINISTERED THE MODERNA VACCINE WHICH IS TO BE ADMINISTERED TO PATIENTS 18YEARS AND OLDER.
This spontaneous report was received from a pharmacist refers to an unknown patient of unknown age. The patient's medical history, concurrent condition and concomitant medications were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX 23. The pharmacist asked if PREVNAR 13 contained phenol before administering the vaccine to a patient allergic to that substance. The pharmacist said that the patient had a really bad reaction after vaccination with PNEUMOVAX 23. The patient had not been vaccinated with PREVNAR 13. The outcome of the event was unknown. Additional information has been requested.
Pfizer covid vaccine was held in freezer past beyond use date, and administered. expired 6/15, given 6/21
Information has been received from a registered nurse concerning an 8 year old female who on 02-MAR-2001 was vaccinated subcutaneous with a first dose of VARIVAX (Merck) and on 12-SEP-2007 was vaccinated subcutaneous with the second dose of VARIVAX (Merck) (LOT# 658421/1029U). On 09-MAY-2008 the patient experienced a full blown case of chicken pox. Subsequently, the patient recovered from chicken pox. Additional information has been requested.
Extreme fatigue; Pain and swelling on the  left arm pit; Pain and swelling moved to my left arm pit.; General sickness; Threw up a little and got all sweaty; Threw up a little and got all sweaty; Headache; Body aches; Left arm became swollen and very painful.; Left arm swollen and very painful; Slept for about 20 hours getting up for a couple hours then becoming so tired I went back to sleep; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 01Sep2021 at 15:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included Crohn's disease of ileum. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT), lisdexamfetamine mesilate (VYVANSE), buspirone hydrochloride (BUSPAR) and vedolizumab (ENTYVIO) all for an unknown indication from an unknown date and unknown if ongoing (also reported as 09Aug). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Sep2021 at 00:00, night after the vaccination, the patient experienced headache and body aches, left arm was swollen and very painful. The patient could not sleep if it got touched or gravity was pulling on it at all and would wake up with a sharp pain. On 03Sep2021 (reported as the following day), the patient experienced extreme fatigue and was tired. The patient slept for about 20 hours and got up for a couple of hours then became so tired and went back to sleep. On the same day, the patient threw up a little and got all sweaty. On day 2, 03Sep2021 after the vaccination, the patient's arm was less swollen but the pain and swelling moved to the left armpit and general sickness and body aches but less than the previous day. It was reported that each following day it got better and swelling went down over the course of the next week. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures taken as a result of the events headache, body aches, left arm swollen and painful  which included unspecified pain medication which helped her to get to sleep but it did not take all the pain away. No therapeutic measures were taken as a result of the events extreme fatigue, tired, threw up a little and got all sweaty, left arm swollen, pain and swelling of the left arm pit and general sickness. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, body aches, extreme fatigue, tired, threw up a little and got all sweaty, left arm swollen and very painful, pain and swelling of the left arm pit and general sickness were resolved on an unknown date in Sep2021.
Off and on Extreme fatigue, mild nausea, dizziness, headache, joint and back pain, blurry vision, hot flashes
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old patient received BNT162b2 (BNT162B2), on 24Mar2022 as dose 4 (booster), single (Lot number: FJ991) at the age of 76 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 2 diabetes" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN, start date: Jan2000, stop date: Jun2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Jun2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: tested positive on two different home antigen tests; (unspecified date) Positive, notes: tested positive on two different home antigen tests; (25May2022) Negative, notes: tested negative the morning of 25May2022. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: No known allergies were noted. The patient took COVID 19 treatment with Paxlovid (Treatment start date: 20May2022, Treatment stop date: 25May2022) and tested negative on the morning of 25May2022. On 26May2022, the patient flew home. Since then, had virtually no contact with anyone. Today (unspecified date), the patient had a sore throat.
Rash started out on left leg, spread to right leg, than all over body.  Treated twice over the course of month with allergy medication, topical solution and prednisone. Pneumonia lasted for month, then had difficulty breathing, shortness of breath, chest pains, arthritis diagnosed, and diabetes diagnosed.
Pericarditis, swelling in major organs including kidneys , liver, heart and lungs
Pain at the injection sight; Muscle soreness; Headache; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3247), via an unspecified route of administration in left arm on 03Mar2021 15:00 (at the age of 31-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included sertraline. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. Patient does not have any known allergies. The patient experienced pain at the injection sight, muscle soreness and headache on 03Mar2021 15:30. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. Outcome of events was resolved on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Hep A vaccine given 02/12/02. Pt states noticed itching and reddness in area where injection given on Sat, 2/16/02. States blisters appeared that Sat. 2/18/02, pt here with son (to interpret) presenting with left deltoid superficial reaction. Quarter size induration with smaller blister at roughly 2:00 on clock face. Area does not appear infected Instructed on wound cleaning and to contact if symptoms worsen
Pt stated that they are vaccinated for COVID. Unknown dates or manufacturer. Now hospitalized and COVID+
Patient received the vaccine and was instructed to sit for 15 minutes as required before leaving. About five to ten minutes to, we were alerted that the patient had fainted. Upon coming to the patient, he was starting to come to but was out of it. I tried asking the patient how he was feeling, is he having a hard time breathing? Patient's entire arms and legs were bright red with possible rashes that lasted about 5 minutes and went away quick. Patient's face remained their normal shade. Patient reported he fell asleep and patient's father reported waking the patient up prior to coming to get his vaccine. Patient sat at the pharmacy to be monitored for an addition 30 minutes before leaving with father. Patient was given water and fan to help cool him down. Patient reported feeling ok after about 10 minutes with legs elevated but was instructed to sit for longer than that time. Patient was ok to leave with father after 30+ minutes of monitoring.
Resident was given PREVNAR 13 on 4/8/2016. A red rash started at injection site and grew to 10x12cm by 4/18/2016.
1 hour after administration, patient's lips tingling and she experienced swelling as well. Patient received 25mg diphenhydramine and was observed for 30 mins. Symptoms resolved over 30 minutes.
Client 2-5 minutes after vaccine fell out of her chair and hit her head on the ground. Client attended to immediately, when she was rolled over she was unconscious. Epi 0.3 mg im given, feet elevated as she laid on the ground. Client awoke. 911 called and client sent to ED.
Vaccine given on0 2/03/2021 & 2nd dose on 02/27/2021 February 18,2021 shortness of breath, fatigue, loss of appetite, sleepy, This continues until March 18, 2021. Saw Physicians Assistant 04,15,2021. Ekg taken.  Heart had irregular heart rhythym.March 3, 2021 sent to cardiologist, Doctor. Diagnosis: Atrial Fibrulation & Cogestive heart failure.March 4, 2021 took Ecocardiogram. Heart  pumping function @ 23%. Hospitalized on March 4, for heart evaluation. Discharged March 7, 2021
Experienced swelling throughout her entire body "from head to toe" / Allergic reaction; Experienced swelling throughout her entire body "from head to toe" / Allergic reaction; This spontaneous report has been received from the mother of the female patient of unknown age. The patient did not have concurrent conditions, pertinent medical history, drug reactions or allergies and was not taking concomitant therapies.    On an unspecifed date in 2005, the patient received one dose of  measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injectionn in the arm (dose, route of administration, lot # and expiration date were not provided) as routine vaccination. Other suspect therapy included measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose, route of administration, lot # and expiration date were not provided) as routine vaccination. The reporter could not recall if the patient received measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) or measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD).   On an unspecified date in 2005, after the vaccination, the patient experienced swelling throughout her entire body form "head to toe" (Swelling). The patient sought medical attention and treatment was given. The reporter stated that the patient did not received the second dose of the vaccine due to the allergic reaction (Hypersensitivity) she experienced with the first dose. On an unspecified date in 2005 (reported as "approximately one week after the vaccination") the patient recovered from the events.   The reporter did not assess the relationship between the events and vaccination with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) or measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD).
Chills, aches, headache, fatigue, and fever of 103.9 for 36 hours for the second shot. Fever was 101.9 on first.
Immediate swelling and bruising after administration. Patient now has extensive bruising on arm approx. 3 inches in diameter. No pain.
Patient received c19 vaccine Pfizer - lot EW0178 at 1437 on 5/26/021   At 1443, patient was given 0.15mg Epi in left thigh due to reaction.    BP 104/68 P: 63 O2: 97% RA (laying) BP 101/70 P: 88 O2: 98% RA (laying)   Patient was seen with her head back in her chair, then sliding down the chair with her eyes rolled and unable to breath.    RN assisted Patient mother at side Lab Mgr present   Patient was kept on the floor until 911 arrived for EMS transport to Hospital.
Fever or chills Cough Shortness of breath or difficulty breathing Fatigue Muscle or body aches Nausea or vomiting Diarrhea
Approx 3 to 4 wks p/receiving Influenza vax, pt devel weakness in quadriceps muscles, w/difficulty climbing stairs & rising from a sitting posiiton, & numbness of feet; dx acquired sensorimotor polyneuropathy, demyelinating type, re-GBS;
Developed constant left deltoid/shoulder pain. Seen by PCP. Was diagnosed with bursitis. Ice and TYLENOL prn were suggested and referred to orthopedic. Seen by dr orthopedic specialist. Diagnosed with rotator cuff tendonitis. He suggested ice 4x/day and TYLENOL prn without improvement in symptoms. Completed physical therapy as ordered without improvement in symptoms. Orthopedic provider suggests steroid injection, I am reluctant to this treatment because there is a risk of a tear to the rotator cuff related to the steroid injection.
On 11/12/15 1st time pt received High Dose Flu vaccine. IM injection given (R) deltoid 2 fingers below acromium process. Sl. bleeding after injection. C/o itching almost immediately after injection cold pack applied x 20 minutes. Slight bruising and swelling spoke w/ patient on 11/13/15. Slight bruise remains. She denies pain, itching or swelling.
6 hrs p/DTP devel vax fever up to 104 & generalized sz;
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2022 at 3:34 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Feb-2022 at 3:34 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that patient ethnicity was white. The patient received Moderna vaccine on 03-Feb-2022 15:34:02, past its 30 day of expiry date. Vaccine went into 2 to 8 degree Celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. No treatment medications were provided.   This case was linked to MOD-2022-542869 (Patient Link).
patient have always gotten the flu; Initial information received on 10-Nov-2022 regarding an unsolicited valid social media non-serious case received from a consumer/non-healthcare professional (hcp).  This case involves an unknown age and unknown gender patient who have always gotten the flu after receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, route, dose: unknown) (lot number and expiry date: not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation).  On an unknown date, the patient developed a non-serious event of have always gotten the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events. It is unknown if there were lab data/results available.   Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (patient have always gotten the flu).  At time of reporting, the outcome was Unknown for the event patient have always gotten the flu.
Body ache; Swelling on the left side of the neck; Lymph glands at the neck are swollen; Tiredness; Blood pressure is high since vaccination; Aspontaneous report was received from a consumer concerning, a 56-year-old female patient who received Moderna (mRNA-1273) vaccine and developed a swelling on the left side of the neck more near to shoulder blade/swelling, body ache, tiredness/fatigue, lymph glands at the neck were swollen/ lymphadenopathy and blood pressure was high since vaccination/hypertension.   The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included cholesterol medications, blood pressure medications and anti-depressants.  On 27 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 10A21A) on the left arm for prophylaxis of COVID-19 infection.  On an unspecified date in 2021, few days post receiving the vaccine, the patient developed a swelling on the left side of the neck more near to shoulder blade. The patient also had body ache, tiredness, lymph glands at the neck were swollen and the blood pressure was high since vaccination.  Treatment information was unknown.   Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, swelling on the left side of the neck more near to shoulder blade/swelling, body ache, tiredness/fatigue, lymph glands at the neck were swollen/ lymphadenopathy and blood pressure was high since vaccination/hypertension were considered as not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I received the vaccine around 9:45 AM on 3-12-21.  By 5:00 PM I had a terrible headache and a 99.8 fever.  Continued to feel unwell throughout the night and very nauseous and body aches.  I forced myself to vomit to relieve the nausea.  Fever spiked to 102.5 overnight and in the morning.  By noon on 3-13-21 I was able to bring the fever down but still had a horrible headache and body aches that remained until 3-14-21 morning.
SkinRash, Rash, 5cm round red non-raised area. Slightly warm to touch. Denies itching Narrative:
Gave Bivalent booster 9/12/2023 instead of new approved booster
On 4/28, I was feeling  some side affects like tired, body pain and joint stiffness . I work at home and I was finished with  work at 7pm. My legs felt like led weights and my right hand had lots of joint pain. I ate supper at 7pm. It was getting towards 8pm and was starting to have signs that Unintentional tremors. shaking in my legs, hands and head. I laid in bed and it was far worse, this was a seizure. was having hard time speaking or breathing at times. I managed to take a clonazepan and with in a hour it starting to calm down.
Symptoms onset during the night of vaccination. High fever, shakiness, difficulty controlling urination, diarrhea, muscle aches all over, heart palpitations, loss of appetite for 3-4 days. Recovered after about a week.